A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy von Deshpande, Alka, Toshniwal, Harsh, Joshi, Shashank, Jani, Rajendrakumar H

Volltext

A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients... von Jani, Rajendrakumar H, Pai, Vikas, Jha, Pramod, Jariwala, Gunjan, Mukhopadhyay, Satinath, Bhansali, Anil, Joshi, Shashank

Volltext

A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (P... von Pai, Vikas, Paneerselvam, A, Mukhopadhyay, Satinath, Bhansali, Anil, Kamath, Dinesh, Shankar, V, Gambhire, Dhiraj, Jani, Rajendrakumar H., Joshi, Shashank, Patel, Pankaj

Volltext

A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adali... von Jani, Rajendrakumar H., Gupta, Rajiv, Bhatia, Girish, Rathi, Gaurav, Ashok Kumar, Patnala, Sharma, Reena, Kumar, Uma, Gauri, Liyakat A., Jadhav, Praveen, Bartakke, Girishchandra, Haridas, Vikram, Jain, Dinesh, Mendiratta, Sanjeev K.

Volltext

Drug approvals in India von Jain, Mukul, Jani, Rajendrakumar H

Volltext